Welch Group, LLC Abb Vie Inc. Transaction History

Welch Group, LLC

$2.29 Billion
Q3 2024

A detailed history of Welch Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Welch Group, LLC holds 360,199 shares of ABBV stock, worth $68.2 Million. This represents 3.1% of its overall portfolio holdings.

Number of Shares

360,199

Previous 359,639 0.16%

Holding current value

$68.2 Million

Previous $61.7 Million 15.31%

% of portfolio

3.1%

Previous 2.97%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$163.84 - $199.33 $91,750 - $111,624	560 Added 0.16%	360,199 $71.1 Million
Q2 2024 Jul 17, 2024	BUY	$154.79 - $180.76 $340,228 - $397,310	2,198 Added 0.61%	359,639 $61.7 Million
Q1 2024 Apr 09, 2024	SELL	$159.82 - $182.1 $1.84 Million - $2.1 Million	-11,505 Reduced 3.12%	357,441 $65.1 Million
Q4 2023 Jan 22, 2024	BUY	$137.6 - $154.97 $751,708 - $846,601	5,463 Added 1.5%	368,946 $57.2 Million
Q3 2023 Oct 18, 2023	BUY	$133.59 - $154.65 $26,851 - $31,084	201 Added 0.06%	363,483 $54.2 Million
Q2 2023 Jul 18, 2023	BUY	$132.51 - $164.9 $395,012 - $491,566	2,981 Added 0.83%	363,282 $48.9 Million
Q1 2023 Apr 13, 2023	SELL	$144.61 - $166.54 $1.34 Million - $1.54 Million	-9,237 Reduced 2.5%	360,301 $57.4 Million
Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $567,762 - $680,896	-4,105 Reduced 1.1%	369,538 $59.8 Million
Q3 2022 Oct 13, 2022	BUY	$134.21 - $153.93 $373,372 - $428,233	2,782 Added 0.75%	373,643 $50.1 Million
Q2 2022 Jul 21, 2022	SELL	$137.62 - $174.96 $1.02 Million - $1.3 Million	-7,446 Reduced 1.97%	370,861 $56.8 Million
Q1 2022 Apr 29, 2022	SELL	$131.98 - $163.75 $382,873 - $475,038	-2,901 Reduced 0.76%	378,307 $61.3 Million
Q4 2021 Jan 26, 2022	BUY	$107.43 - $135.93 $916,377 - $1.16 Million	8,530 Added 2.29%	381,208 $51.6 Million
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $475,395 - $539,645	4,468 Added 1.21%	372,678 $40.2 Million
Q2 2021 Jul 21, 2021	BUY	$105.21 - $117.21 $125,515 - $139,831	1,193 Added 0.33%	368,210 $41.5 Million
Q1 2021 Apr 23, 2021	SELL	$102.3 - $112.62 $695,333 - $765,478	-6,797 Reduced 1.82%	367,017 $39.7 Million
Q4 2020 Jan 25, 2021	SELL	$80.49 - $108.67 $491,149 - $663,104	-6,102 Reduced 1.61%	373,814 $40.1 Million
Q3 2020 Oct 28, 2020	SELL	$85.91 - $100.83 $449,051 - $527,038	-5,227 Reduced 1.36%	379,916 $33.3 Million
Q2 2020 Jul 22, 2020	SELL	$73.37 - $98.18 $298,836 - $399,887	-4,073 Reduced 1.05%	385,143 $37.8 Million
Q1 2020 Apr 28, 2020	BUY	$64.5 - $97.79 $1.8 Million - $2.73 Million	27,927 Added 7.73%	389,216 $29.7 Million
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $633,734 - $792,936	8,786 Added 2.49%	361,289 $32 Million
Q3 2019 Nov 05, 2019	BUY	$62.98 - $75.72 $2.08 Million - $2.5 Million	33,042 Added 10.34%	352,503 $26.7 Million
Q2 2019 Jul 11, 2019	BUY	$65.7 - $83.98 $1.42 Million - $1.82 Million	21,654 Added 7.27%	319,461 $23.2 Million
Q1 2019 Apr 15, 2019	BUY	$77.14 - $90.79 $892,509 - $1.05 Million	11,570 Added 4.04%	297,807 $24 Million
Q4 2018 Jan 10, 2019	BUY	$77.85 - $96.01 $313,034 - $386,056	4,021 Added 1.42%	286,237 $26.4 Million
Q3 2018 Nov 01, 2018	BUY	$88.91 - $98.84 $286,734 - $318,759	3,225 Added 1.16%	282,216 $26.7 Million
Q2 2018 Jul 30, 2018	SELL	$89.78 - $106.23 $535,807 - $633,980	-5,968 Reduced 2.09%	278,991 $25.8 Million
Q1 2018 Apr 23, 2018	BUY	$92.01 - $123.21 $3.8 Million - $5.09 Million	41,303 Added 16.95%	284,959 $27 Million
Q4 2017 Feb 01, 2018	SELL	$89.56 - $98.21 $947,097 - $1.04 Million	-10,575 Reduced 4.16%	243,656 $23.6 Million
Q3 2017 Nov 07, 2017	SELL	$69.85 - $89.22 $457,727 - $584,658	-6,553 Reduced 2.51%	254,231 $22.6 Million
Q2 2017 Aug 07, 2017	BUY	N/A	260,784	260,784 $18.9 Million

Others Institutions Holding ABBV

# of Institutions

3,757

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.84M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $335B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch Group, LLC with notifications on news.

Account